Patterson Companies (NASDAQ:PDCO) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Patterson Companies (NASDAQ:PDCO) in a research note released on Tuesday morning. The brokerage issued a hold rating on the stock.

Patterson Companies Price Performance

PDCO stock opened at $31.33 on Tuesday. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34. The firm has a 50-day moving average of $31.21 and a two-hundred day moving average of $28.55. Patterson Companies has a 12 month low of $19.45 and a 12 month high of $31.79. The company has a market cap of $2.77 billion, a price-to-earnings ratio of 18.32, a PEG ratio of 2.71 and a beta of 0.73.

Hedge Funds Weigh In On Patterson Companies

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Curat Global LLC acquired a new position in shares of Patterson Companies during the 1st quarter valued at about $25,000. Harbour Investments Inc. purchased a new position in Patterson Companies during the fourth quarter worth about $26,000. Huntington National Bank boosted its holdings in Patterson Companies by 54.0% in the 4th quarter. Huntington National Bank now owns 1,115 shares of the company’s stock valued at $34,000 after purchasing an additional 391 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Patterson Companies by 103.0% in the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock valued at $41,000 after buying an additional 680 shares during the period. Finally, Quadrant Capital Group LLC increased its holdings in shares of Patterson Companies by 501.6% during the 4th quarter. Quadrant Capital Group LLC now owns 1,883 shares of the company’s stock worth $58,000 after buying an additional 1,570 shares during the last quarter. Institutional investors and hedge funds own 85.43% of the company’s stock.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.